NGF and early-onset autosomal dominant Alzheimer disease: Exogenous NGF has shown excellent therapeutic efficacy in cell experiments in Alzheimer's disease, Parkinson's disease, hemorrhagic stroke, diabetic peripheral neuropathy, optic nerve injury and other disease models [1–6].